UK markets open in 3 hours 41 minutes

Alto Neuroscience, Inc. (ANRO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
12.44+0.63 (+5.33%)
At close: 04:00PM EDT
12.44 0.00 (0.00%)
After hours: 04:06PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Cash flows from operating activities
Net income
-42,438
-36,305
-27,710
-9,187
Depreciation & amortisation
384
373
342
145
Stock-based compensation
4,586
2,891
1,763
227
Change in working capital
23
-698
4,579
-572
Accounts receivable
-
325
1,158
-1,285
Accounts payable
1,137
-632
1,006
458
Other working capital
-37,580
-33,918
-21,126
-9,942
Other non-cash items
669
676
263
18
Net cash provided by operating activities
-36,907
-33,448
-20,394
-9,262
Cash flows from investing activities
Investments in property, plant and equipment
-673
-470
-732
-680
Net cash used for investing activities
-673
-470
-732
-680
Cash flows from financing activities
Common stock issued
137,760
181
43
7
Other financing activities
-
-2,051
-341
-205
Net cash used provided by (used for) financing activities
177,689
68,130
43,789
31,688
Net change in cash
140,115
34,204
22,639
21,696
Cash at beginning of period
65,780
48,344
25,705
4,009
Cash at end of period
205,889
82,548
48,344
25,705
Free cash flow
Operating cash flow
-36,907
-33,448
-20,394
-9,262
Capital expenditure
-673
-470
-732
-680
Free cash flow
-37,580
-33,918
-21,126
-9,942